SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-135289
Filing Date
2024-05-09
Accepted
2024-05-09 16:18:40
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d825241ds3.htm S-3 182655
2 EX-5.1 d825241dex51.htm EX-5.1 11348
3 EX-23.1 d825241dex231.htm EX-23.1 3054
4 EX-FILING FEES d825241dexfilingfees.htm EX-FILING FEES 16961
5 GRAPHIC g825241dsp1.jpg GRAPHIC 3431
6 GRAPHIC g825241dsp2.jpg GRAPHIC 2651
7 GRAPHIC g825241g08k04.jpg GRAPHIC 36321
8 GRAPHIC g825241snap1.jpg GRAPHIC 2884
9 GRAPHIC g825241snap2.jpg GRAPHIC 2001
  Complete submission text file 0001193125-24-135289.txt   276963
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279261 | Film No.: 24930980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)